Earlier this year, we regrettably had to cancel the USA Summit in Washington and then the November Summit in London, due to Covid restrictions.

While it isn’t possible to welcome you in person, transitioning the Summit event online has given us the opportunity to create an event without geographical borders, combining the most compelling content on the science, evidence, policy and public health from an unparalleled line up of the leading scientists and researchers from across the globe.

We are delighted to publish the full agenda for The Virtual E-Cigarette Summit which will take place December 3-4.  While we would ideally love for everyone to be able to join us for the live event, we appreciate that multiple time zones and challenging schedules means that joining the Summit for the duration in real time may be difficult, so we have designed the agenda to work as individual sessions which can be viewed on demand from December 1st.   The Panel Debates and Q&A sessions will be live during their scheduled times (See Agenda) but you will have the opportunity to pose questions in advance and watch back later.

We hope that the Virtual Summit will provide a welcoming focal point to grapple with the challenging questions posed by  e-cigarettes and new novel nicotine products.  Although Covid, Brexit and the US Presidential Election dominate our news media, there is a considerable amount of change happening in the public health, policy and regulatory environments related to tobacco, e-cigarettes and harm reduction.

For decades, the known harms from smoking and combustible products has aligned public health and tobacco control colleagues behind a known “enemy”.  The emergence of less harmful alternatives has resulted in a heated debate that continues to divide scientists, health professionals and policy makers alike.  The E-Cigarette Summit has a single aim of facilitating respectful dialogue and thoughtful analysis of the latest research and exploring how the evidence should be interpreted, to deliver the most effective health strategies to reduce smoking related death and disease.  We hope that you can join us.


Prof Ann McNeill

Professor of Tobacco Addiction,

Kings College London

Prof Ann McNeill, Professor of Tobacco Addiction & Vice Dean, Kings College London

Martin Dockrell

Tobacco Control Programme Lead,

Public Health England

Martin Dockrell, Tobacco Control Programme Lead, PHE

Prof Robert West

Emeritus Professor of Health Psychology, University College London

Prof Robert West, Emeritus Professor of Health Psychology, University College London

Prof Thomas Glynn

Stanford University School of Medicine

Prof Thomas J. Glynn
Adjunct Lecturer, Stanford University School of Medicine


Paul Lincoln OBE

Chair - Tobacco: preventing uptake, promoting quitting and treating tobacco dependence

(NICE) National Institute of Clinical and Health Excellence -

Deborah Arnott

Chief Executive

Action on Smoking and Health

Hazel Cheeseman

Deputy Chief Executive & Policy Director

ASH (Action on Smoking & Health)

Ben Youdan


ASH New Zealand

Dr Colin Mendelsohn MB BS (Hons)

General practitioner, Founding Chairman

Australian Tobacco Harm Reduction Association

Nicky Coote

Service Lead & Specialist Smoking Cessation Practitioner

Barnet Stop Smoking Service, Public Health

Dr Jasjit S. Ahluwalia

Physician and Professor

Brown University School of Public Health and Alpert Medical School

Prof Daniel Kotz

Professor in addiction research and clinical epidemiology, Institute of General Practice

Centre for Health and Society, Medical Faculty of the Heinrich-Heine-University Düsseldorf, Germany

Louise Ross

Clinical Consultant, NCSCT

Chair and Mental Health Lead, New Nicotine Alliance

Prof Lion Shahab

Professor of Health Psychology, University College London

Co-Director of the UCL Tobacco and Alcohol Research Group

Prof Linda Bauld, OBE

Bruce and John Usher Chair in Public Health in the Usher Institute

College of Medicine, University of Edinburgh

Clive Bates


Counterfactual Consulting Ltd

Dr Michael Pesko

Health Economist & Associate Professor

Department of Economics, Andrew Young School of Policy Studies, Georgia State University

Tim Phillips

Managing Director


Dr Sharifa Ezat Wan Puteh

Professor of Hospital Management and Health Economics and Deputy Dean (Relation & Wealth Creation)

Faculty of Medicine, UKM Medical Centre

Stefanie Miller

Managing Director

FiscalNote Markets

Stefaan Hendrickx

Senior Staff Member Tobacco

Flemish Institute for Healthy Living

Ailsa Rutter OBE


Fresh and Balance

Prof Tikki Pang

Former Director, Research, Policy & Cooperation, World Health Organization

Geneva, Switzerland

Andrea Crossfield MBE

Independent Public Health Consultant and Population Health Policy Specialist

Greater Manchester Health and Social Care Partnership

Associate Prof Sivakumar Thurairajasingam

Associate Professor in Psychiatry

Head of the Clinical School Johor Bahru, Monash University Malaysia

Liam Humberstone

Technical Director at Totally Wicked


Prof Alan Boobis, OBE

Emeritus Professor of Toxicology & Chair - UK Committee on Toxicity

Imperial College London

Marcus Saxton


Independent British Vape Trade Association (IBVTA)

Prof Ann McNeill

Professor of Tobacco Addiction

Institute of Psychiatry, Psychology & Neuroscience, King's College London

Eve Taylor MSc

PHD Student and Research Assistant - Nicotine Research Group

King's College London (KCL)

Prof David Levy

Professor of Oncology

Lombardl Comprehensive Cancer Center, Georgetown University

Prof Virginia Berridge

Professor of History and Health Policy, Centre for History in Public Health

London School of Hygiene & Tropical Medicine, London, UK

Kate Pike

Co-ordinator - Trading Standards North West

Member of the Department of Health and Social Care National Tobacco Focus Group

Craig Copland

Head of E-Cigarettes, Healthcare, Quality and Access Group

MHRA - The Medicines and Healthcare products Regulatory Agency

Dr Debbie Robson RMN, PhD

Senior Lecturer in Tobacco Harm Reduction

National Addiction Centre, Institute of Psychiatry, Psychology & Neuroscience, King’s College London

David Graham

Chief Impact Officer


Louise Ross

Vice Chair


Marc Gunther


Nonprofit Chronicles/Freelance

Rachel McIlvenna

Smokefree NHS Strategic Manager

North East and North Cumbria ICB

Richard Holley

Area Manager (Smoking Cessation), Tobacco Control Lead

Northamptonshire Stop Smoking Service

Dr Karl E. Lund

Senior Researcher

Norwegian Institute of Public Health

Dr Jamie Hartmann-Boyce

Associate Professor and Editor Cochrane Tobacco Addiction Group

Nuffield Department of Primary Care Health Sciences, University of Oxford

Rosanna O’Connor

Director, Addictions & Inclusion

Office for Health Improvement & Disparities, Department of Health and Social Care


Director of Public Health Analysis

Office for Health Improvement and Disparities (OHID)

Martin Dockrell

Tobacco Control Programme Lead

Office of Health Improvement & Disparities (OHID)

Speaker TBC

Speaker to be confirmed


Pascal Diethelm



Dr Winston Price, M.D., FAAP, FACPE

Associate Professor

Philadelphia College of Osteopathic Medicine, CTIO-W. Montague Cobb/NMA Health Institute

Karl Fagerstrom

Professor Emeritus

President, Fagerstrom Consulting

Dr Garrett McGovern

GP and Medical Director

Priority Medical Clinic

Prof Geoffrey T. Fong, OC, Ph.D., FRSC, FCAHS

Founder and Chief Principal Investigator of the International Tobacco Control Policy Evaluation Project

Professor of Psychology and Public Health and Health Systems, University of Waterloo

Speaker TBC

Speaker to be confirmed


Dr Ruth Sharrock

Clinical Lead for Tobacco Dependency for the North East & North Cumbria ICS

Respiratory Consultant, Queen Elizabeth Hospital - Gateshead

Prof Maciej L. Goniewicz

Professor of Oncology, Department of Health Behavior, Division of Cancer Prevention and Population Studies

Roswell Park Comprehensive Cancer Center

Ray Niaura

Interim Chair of Dep't of Epidemiology, Professor of Social and Behavioural Sciences

School of Global Public Health, New York University

Professor Marcus Munafò

Professor of Biological Psychology and MRC Investigator

School of Psychological Science, University of Bristol

Tom Sheldon

Senior Press Manager

Science Media Centre

Dr Frances Thirlway

Research Fellow

Sociology Department, University of York

Prof Thomas J. Glynn, PhD

Adjunct Lecturer

Stanford Prevention Research Center, Stanford University School of Medicine

Mitch Zeller, J.D

Director (Retired) Center for Tobacco Products (CTP)

The Food & Drug Administration (FDA)

Prof Wayne Hall

Professor Emeritus, National Centre for Youth Substance Use Research

The University of Queensland

Professor Robert West

Professor Emeritus of Health Psychology

University College London

Prof Martin Jarvis

Emeritus Professor of Health Psychology, Department of Behavioural Science & Health

University College London

Dr Sharon Cox

Senior Research Fellow

University College London

Dr Harry Tattan-Birch

Research Fellow

University College London (UCL)

Sarah Jackson

Principal Research Fellow Behavioural Science and Health

University College London (UCL)

Prof Sanjay Agrawal

Professor of Respiratory Science, Institute of Lung Health

University Hospitals of Leicester NHS Trust, Special Advisor on Tobacco, Royal College of Physicians

Prof Robert Beaglehole

Emeritus Professor

University of Auckland, New Zealand & Chair ASH - Action for Smokefree 2025, NZ

Dr Jasmine Khouja

Senior Research Associate

University of Bristol

Prof Steven A. Schroeder, MD

Distinguished Professor of Health and Healthcare

University of California, San Francisco & Director, Smoking Cessation Leadership Center

Prof Jacob George

Professor of Cardiovascular Medicine and Therapeutics

University of Dundee

Prof Caitlin Notley

Chair of Addiction Sciences

University of East Anglia

Prof Robin Mermelstein

Distinguished Professor of Psychology & Director, Institute for Health Research and Policy

University of Illinois, Chicago

Assistant Prof Jamie Hartmann-Boyce

Assistant Professor in Health Promotion and Policy

University of Massachusetts Amherst

Cliff Douglas JD

Director, Tobacco Research Network, Adjunct Professor, Dep't of Health Management and Policy

University of Michigan School of Public Health

Prof Kenneth Warner

Avedis Donabedian Distinguished University Professor Emeritus of Public Health and Dean Emeritus

University of Michigan School of Public Health

Prof Dorothy Hatsukami

Professor, Department of Psychiatry and Behavioral Sciences

University of Minnesota

Dr Konstantinos Farsalinos M.D

External Research Associate

University of Patras, Department of Public and Community Health, University of West Attica, Greece

Prof Peter Hajek

Director of the Health and Lifestyle Research Unit

Wolfson Institute of Population Health, Queen Mary University of London

Assoc Prof Abigail S. Friedman

Department of Health Policy & Management

Yale School of Public Health


The Virtual E-Cigarette Summit 2020 will provide an inclusive platform to explore the latest research and scientific evidence. The Summit will run across 2 days and will be broken down into 7 separate sessions with a live Q&A opportunity with the panel, after each session:

Day 1 – Thursday 3 December

  • Session 1: Science, Evidence and Research
  • Session 2: Nicotine and Policy
  • Session 3: THR and Public Health Policy

Day 2 – Friday 4 December

  • Session 4: Tobacco Control, Industry and Regulation
  • Session 5: Working with Tobacco Harm Reduction
  • Session 6: Tobacco and Health Inequalities
  • Session 7: Tobacco Control and THR

Keynote and closing address – Tobacco Control, Harm Reduction, and Science: Integrity is our most Important Asset


In particular, this event will be relevant to:

  • Regulators and policy/government advisors
  • Scientific/academic research community
  • Clinical Commissioning Groups/PCT’s
  • Smoking cessation practitioners/services
  • Health charities and health campaigners
  • Public health professionals
  • Medical/health practitioners
  • Industry and other stakeholders

The Summit independently provides hosted places for vapers and individuals without funding to attend.  These places are discretionary and are considered on a case by case basis.  If you would like to find out more please email


  • Regulators and policy/government advisors
  • Scientific/research community
  • Smoking cessation practitioners/services
  • Health charities and health campaigners
  • Public health professionals and academics
  • Medical and health practitioners
  • Industry and other stakeholders

The Summit independently provides hosted places for vapers and individuals without funding to attend.  These places are discretionary and are considered on a case by case basis.  If you would like to find out more please contact us by email on